Bacterin International Holdings Inc  

(Public, NYSEMKT:BONE)   Watch this stock  
Find more results for NYSEAMEX:BONE
2.86
-0.17 (-5.61%)
Nov 25 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 2.85 - 3.06
52 week 2.19 - 14.10
Open 3.04
Vol / Avg. 0.00/29,539.00
Mkt cap 19.54M
P/E     -
Div/yield     -
EPS -2.03
Shares 6.68M
Beta 2.42
Inst. own 33%
Nov 20, 2014
Bacterin International Holdings Inc at Singular Research Best of the Uncovereds Conference
Nov 6, 2014
Q3 2014 Bacterin International Holdings Inc Earnings Call
Nov 5, 2014
Q3 2014 Bacterin International Holdings Inc Earnings Release
Oct 14, 2014
Preliminary 2014 Bacterin International Holdings, Inc. Earnings Release
Sep 22, 2014
Bacterin International Holdings Inc at Singular Research Best of the Uncovereds Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -13.79% -38.38%
Operating margin -14.79% -27.24%
EBITD margin - -22.75%
Return on average assets -15.53% -40.06%
Return on average equity - -6505.79%
Employees 128 -
CDP Score - -

Address

600 Cruiser Lane
BELGRADE, MT 59714
United States - Map
+1-406-3880480 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Bacterin International Holdings Inc is a United States-based tissue bank and medical device company. The Company designs, processes, manufactures, and markets advanced medical products. Its a specialty tissue bank focused on processing and distributing allografts to the patients. It utilizes BacteRinse Sterile Technology to process its allografts. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM Putty, OsteoWrap, OrbitalWrap HD, Facet Stabilization, Milled Cervical Spacers, Traditional Allografts, hMatrix ADM, hMatrix PR ADM, Sports Medicine, Elutia Wound Drains and OsteoSTX.

Officers and directors

Kent L. Swanson Independent Acting Chairman of the Board
Age: 69
Bio & Compensation  - Reuters
Robert Di Silvio President
Age: 61
Bio & Compensation  - Reuters
Daniel S. Goldberger Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
John P. Gandolfo Chief Financial Officer
Age: 53
Bio & Compensation  - Reuters
Darrel Lee Holmes Chief Operating Officer
Age: 60
Bio & Compensation  - Reuters
Gregory Juda Ph.D. Chief Scientific Officer
Age: 38
Bio & Compensation  - Reuters
David E. Goodman M.D. Director
Age: 58
Bio & Compensation  - Reuters
John Deedrick Independent Director
Age: 51
Bio & Compensation  - Reuters
Michael A. Lopach CPA Independent Director
Age: 65
Bio & Compensation  - Reuters
Jon M. Wickwire Independent Director
Age: 70
Bio & Compensation  - Reuters